19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace

 

 

 

 


powered by centersite dot net
Pain Management
Resources
Basic InformationLatest News
Nagging Low Back Pain? Try MindfulnessOpioids Plus Other Drugs a Deadly Mix for Heavy UsersHealth Tip: Manage Pain With OpioidsDoctors More Cautious Now When Prescribing Opioids to KidsEven Wisdom Tooth Removal May Spur Opioid AddictionOnly a Quarter of Opioid Painkillers Taken After Most SurgeriesOpioid Use May Sometimes Trigger A-FibFDA Approves Powerful New Opioid Despite CriticismsA New Challenger to Medical Marijuana?New Nerve Stimulation Technique Might Relieve Back PainDespite Opioid Crisis, Most Patients Want the Drugs for Post-Op PainFor Pain Relief, Why Not Try Drug-Free Alternatives?1 in 12 Americans Lives With Debilitating Chronic PainMindfulness May Be a Buffer Against PainCould a Placebo Pill Help Ease Your Back Pain?Chronic Pain May Drive Some to SuicideMonkey Trials Raise Hope for Non-Addictive Opioid AlternativeGovernment Rules Aimed at Curbing Opioid Prescriptions May Have BackfiredAs Opioid Epidemic Rages, Painkiller Prescriptions Don't DropMost Seniors Uninformed on Opioid UseSprained Ankle? Opioid Rx More Likely in Some States Than OthersOpioids Before Joint Replacement Tied to Worse RecoveryCould Botox Cousin Combat the Opioid Epidemic?Where Are Opioid Painkillers Prescribed the Most?Anti-seizure Meds Won't Ease Low Back PainMedical Marijuana a Hit With SeniorsRisky Prescribing Boosts Opioid Death RiskPatients on Opioids OK With Lower DosesPatterns of Potential Misuse Help Assess Risk of Opioid OverdoseHospitals Should, and Could, Avoid IV Opioids: StudyOpioid Makers' Perks to Docs Tied to More PrescriptionsPsychological Therapies May Help Older Adults With Chronic PainStudy Finds 31 Percent Use No Opioids After SurgeryAddictive Opioids Still Overprescribed After Surgery: StudyDoctors Curbing First-Time Prescriptions for OpioidsFDA Recalls Kratom Products Due to Salmonella ThreatMillions Get Wrong Treatment for Back Pain: StudyManaging Pain With Fewer Opioids After Joint ReplacementDoctors Present Recs For and Against Acupuncture for PainOpioids Don't Top Non-Opioids for Pain-Related FunctionOpioids Not Best Option for Back Pain, Arthritis, Study FindsGroup CBT, Pain Education Improve Pain, Physical FunctionChronic Opioid Users May Wish to Taper Opioid UseSome Pain Patients Can Cut Opioid Dose and Still Get ReliefAnother Downside to Opioid Use: Pneumonia?Long-Term Opioid Use Down Among U.S. Vets: StudyLosing Weight Eases Obesity-Related Pain. But How Much Is Enough?Do Over-the-Counter Painkillers Alter Emotions, Reasoning?Opioid Prescribing Trends in the VA Similar to Other SettingsHow to Avoid Opioid Addiction After Surgery
Questions and AnswersVideosLinksBook Reviews
Related Topics

Depression: Depression & Related Conditions
Mental Disorders
Medications

Monkey Trials Raise Hope for Non-Addictive Opioid Alternative

HealthDay News
by -- Robert Preidt
Updated: Aug 30th 2018

new article illustration

THURSDAY, Aug. 30, 2018 (HealthDay News) -- The ongoing opioid addiction crisis means the search for powerful but non-addictive painkillers is more urgent than ever before. Now, a team of scientists says it may be nearing that goal.

Research in monkeys suggests that an experimental painkiller -- called AT-121 -- is not only very effective in easing pain, but it may also blunt the addictive effects of opioids.

AT-121 provided the same level of pain relief as a typical opioid, but at a 100-times lower dose than morphine, according to the research team from Wake Forest Baptist Medical Center, in Winston-Salem, N.C.

"In our study, we found AT-121 to be safe and non-addictive, as well as an effective pain medication," said Mei-Chuan Ko, a professor of physiology and pharmacology at the hospital.

"In addition, this compound also was effective at blocking abuse potential of prescription opioids, much like buprenorphine does for heroin, so we hope it could be used to treat [both] pain and opioid abuse," Ko added in a Wake Forest news release.

The research showed that -- in monkeys, at least -- AT-121 suppressed the addictive potential of oxycodone (Oxycontin), a commonly abused opioid prescription drug.

In the experiments, monkeys were able to "self-administer" potentially addictive drugs such as cocaine or oxycodone, but when given AT-121, they were no more likely to do so than when they'd received simple saline solutions.

According to Ko's team, this suggests that AT-121 lacks the addictive potential of typical opioids.

And unlike typical opioids, withdrawal symptoms weren't observed when the monkeys ceased using AT-121 after three days, the researchers said.

AT-121 also seemed to ease pain without some of the typical side effects of opioids, such as itch, motor impairment, respiratory and other issues.

Of course, trials conducted in animals sometimes fail to pan out in people. But Ko noted that monkeys are a very close model to humans.

"The fact that this data was in non-human primates, a closely related species to humans," suggests that the findings have a good chance of being replicated in clinical trials in people, he said.

Still, further research -- including safety studies -- is needed before applying to the U.S. Food and Drug Administration for approval to conduct those clinical trials, Ko said.

The study was published Aug. 29 in the journal Science Translational Medicine.

More information

The U.S. National Institute on Drug Abuse has more about prescription opioids.